AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $665,496 | +79.4% | 23,700 | +109.7% | 0.01% | +100.0% |
| Q4 2021 | $371,000 | -69.4% | 11,300 | -48.7% | 0.00% | -76.9% |
| Q2 2021 | $1,214,000 | -15.2% | 22,035 | -20.6% | 0.01% | -23.5% |
| Q1 2021 | $1,432,000 | +82.4% | 27,736 | +23.7% | 0.02% | +13.3% |
| Q3 2020 | $785,000 | +15.8% | 22,428 | +77.0% | 0.02% | +66.7% |
| Q2 2020 | $678,000 | +196.1% | 12,668 | +95.9% | 0.01% | -35.7% |
| Q1 2020 | $229,000 | -60.6% | 6,468 | -41.2% | 0.01% | -85.9% |
| Q3 2016 | $581,000 | +82.7% | 11,000 | +40.3% | 0.10% | -23.8% |
| Q1 2016 | $318,000 | – | 7,841 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |